Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 05, 2015 9:17 AM ET


Company Overview of Intarcia Therapeutics, Inc.

Key Executives for Intarcia Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Kurt C. Graves 48 RelationshipsExecutive Chairman, Chief Executive Officer and President46
James M. Ahlers No RelationshipsChief Financial Officer and Vice President of Finance & Operations50
Thomas R. Alessi Ph.D.No RelationshipsVice President of Development & Manufacturing55
Michelle Baron M.D., FACENo RelationshipsChief Medical Officer and Vice President of Clinical Research--
Owen P. Hughes Jr.11 RelationshipsChief Business Officer and Head of Corporate Development39
View More Key Executives

Intarcia Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kurt C. Graves 48 RelationshipsIntarcia Therapeutics, Inc.46
Bryan E. Roberts Ph.D. 163 RelationshipsCastlight Health, Inc.47
Glen Y. Sato J.D., M.B.A. 92 RelationshipsCooley LLP55
Irwin Scher M.D. 6 RelationshipsBiosynexus Incorporated64
Gino Santini 74 RelationshipsAMAG Pharmaceuticals, Inc.57
View All Board Members

Intarcia Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Intarcia Therapeutics, Inc. CEO Compensation
Industry Average


SCA Announces Resignation of Rolf Börjesson as Member of the Board of Directors
May 04, 2015 5:57 AM ET
Energizer Holdings Inc. Announce Composition of New Boards of Directors
April 27, 2015 9:00 PM ET
Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intarcia Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at